Michael Derks
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Co-authors
- Mary C. Phelan (6 shared papers)Markus Abt (5 shared papers)Olaf Kuhlmann (2 shared papers)Stephen Fowler (2 shared papers)Georgina Meneses‐Lorente (4 shared papers)Christoph Wandel (6 shared papers)Lisa Squassante (4 shared papers)Federico Bolognani (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (3 papers)Clinical Therapeutics (2 papers)European Neuropsychopharmacology (2 papers)Expert Opinion on Investigational Drugs (2 papers)Journal of Pharmacokinetics and Pharmacodynamics (2 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Michael Derks
23 papers receiving 296 citations
Peers
Comparison fields: 5 of 61
- Endocrinology, Diabetes and Metabolism 74
- Biological Psychiatry 8
- Cancer Research 48
- Pharmacology 26
- Surgery 123
Countries citing papers authored by Michael Derks
This map shows the geographic impact of Michael Derks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Derks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Derks more than expected).
Fields of papers citing papers by Michael Derks
This network shows the impact of papers produced by Michael Derks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Derks. The network helps show where Michael Derks may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Derks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 75 | |
| 2 | 2009 | 24 | |
| 3 | 2021 | 24 | |
| 4 | 2010 | 22 | |
| 5 | 2009 | 21 | |
| 6 | 2010 | 18 | |
| 7 | 2011 | 17 | |
| 8 | 2011 | 17 | |
| 9 | 2011 | 16 | |
| 10 | 2010 | 14 | |
| 11 | 1988 | 13 | |
| 12 | 2010 | 12 | |
| 13 | 2017 | 7 | |
| 14 | 2021 | 5 | |
| 15 | 2018 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2012 | 4 | |
| 18 | 2013 | 2 | |
| 19 | 2020 | 2 | |
| 20 | 2011 | 2 |
About Michael Derks
Michael Derks is a scholar working on Oncology, Surgery, Molecular Biology, Social Psychology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 307 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Lipoproteins and Cardiovascular Health (5 papers), Receptor Mechanisms and Signaling (4 papers), Neuroendocrine regulation and behavior (4 papers), Electrolyte and hormonal disorders (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (74 citations), Biological Psychiatry (8 citations), Cancer Research (48 citations), Pharmacology (26 citations) and Surgery (123 citations). Michael Derks has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Mary C. Phelan, Markus Abt, Olaf Kuhlmann, Stephen Fowler, Georgina Meneses‐Lorente, Christoph Wandel, Lisa Squassante, Federico Bolognani, Marta del Valle Rubido and Lorraine Murtagh. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical Therapeutics, European Neuropsychopharmacology, Expert Opinion on Investigational Drugs and Journal of Pharmacokinetics and Pharmacodynamics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.